Article info

Download PDFPDF

Benefit versus toxicity risk of digoxin in patients with COVID-19
Free

Authors

  1. Correspondence to Mrs Burcu Kelleci Cakir, Department of Clinical Pharmacy, Hacettepe University Faculty of Pharmacy, 06100 Ankara, Turkey; burcukelleci{at}hacettepe.edu.tr
View Full Text

Citation

Kelleci Cakir B, Bayraktar-Ekincioglu A, Demirkan K
Benefit versus toxicity risk of digoxin in patients with COVID-19

Publication history

  • First published June 2, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.